论文部分内容阅读
目的分析特布他林混悬液、布地奈德混悬液雾化吸入用于治疗毛细支气管炎的临床疗效。方法选取毛细支气管炎患儿162例,随机均分为治疗组和对照组,对照组予以常规治疗,治疗组在对照组的基础上予以特布他林混悬液联合布地奈德混悬液雾化吸入。对比分析两组疗效。结果治疗组的喘憋消失时间、咳嗽及肺部啰音消失时间、住院时间显著短于对照组,P均<0.05;治疗组的显效率及治疗总有效率分别为63.0%和100%,显著高于对照组的21.0%和86.4%,P均<0.05。结论特布他林混悬液与布地奈德混悬液雾化吸入治疗细支气管炎可快速缓解患者的症状及体征,缩短病程以及住院时间,安全简便,疗效显著,值得推广应用。
Objective To analyze the clinical effect of inhalation of terbutaline suspension and budesonide suspension for the treatment of bronchiolitis. Methods 162 cases of children with bronchiolitis were randomly divided into treatment group and control group. The control group was given routine treatment. The treatment group was given terbutaline suspension and budesonide suspension mist on the basis of the control group Inhalation. Comparative analysis of two groups of curative effect. Results The disappearance of wheezing, cough and disappearance of pulmonary rales and hospital stay in treatment group were significantly shorter than those in control group (P <0.05). The effective rate and total effective rate of treatment group were 63.0% and 100% respectively 21.0% and 86.4% of the control group, P <0.05. Conclusion The combination of terbutaline suspension and budesonide aerosol inhalation for the treatment of bronchiolitis can quickly relieve the symptoms and signs of patients, shorten the course of disease and hospital stay, which is safe, simple and effective. It is worth popularizing and applying.